Management of glaucoma: focus on pharmacological therapy.
about
Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)An emerging treatment option for glaucoma: Rho kinase inhibitorsTopical medication instillation techniques for glaucomaAcupuncture for glaucomaAcupuncture for glaucomaRecent advances in pharmacotherapy of glaucomaDrug attitude and adherence to anti-glaucoma medication.Comparative efficacy and safety of the fixed versus unfixed combination of latanoprost and timolol in Chinese patients with open-angle glaucoma or ocular hypertension.Efficacy and tolerability of mono-compound topical treatments for reduction of intraocular pressure in patients with primary open angle glaucoma or ocular hypertension: an overview of reviews.Topical medication instillation techniques for glaucoma.Thermal stability of bimatoprost, latanoprost, and travoprost under simulated daily use.Clinical options for the reduction of elevated intraocular pressureEfficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors1α,25-Dihydroxyvitamin D(3) and its analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D(3) (2MD), suppress intraocular pressure in non-human primates.Topical treatment of glaucoma: established and emerging pharmacology.Extended release of timolol from nanoparticle-loaded fornix insert for glaucoma therapy.Ocular fibroblast types differ in their mRNA profiles--implications for fibrosis prevention after aqueous shunt implantationHow ocular surface disease impacts the glaucoma treatment outcomeDonepezil in severe Alzheimer's disease.Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms.Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety.Review on Hypothetical Implementing TGF-β Family Members in Glaucoma Therapy.Novel drug delivery systems for glaucoma.Antiglaucoma pharmacotherapy.Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenonThe Effect of Eye Drop Technique Education in Patients With Glaucoma.Rho-Associated Kinase Inhibitors: Potential Future Treatments for Glaucoma.Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection.How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique.Tafluprost for the reduction of interocular pressure in open angle glaucoma and ocular hypertension.Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations.Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension.Are guidelines needed for the diagnosis and management of incipient Alzheimer's disease and mild cognitive impairment?Hydrophobic substituents of the phenylmethylsulfamide moiety can be used for the development of new selective carbonic anhydrase inhibitors.Prospective observational post-marketing study of tafluprost for glaucoma and ocular hypertension: short-term efficacy and safety.
P2860
Q22251113-8EA1FF41-11A3-4CED-93F7-CEDA6C2F0C4DQ22305851-9C15AB69-2AFA-4AD0-B456-3299F56493FBQ24197532-2D4A57AB-6633-4FAD-A6E3-F851F895DCCFQ24202822-8D0BC003-F671-49EB-8944-DA5C8D8A4098Q24242871-BEF3AAFF-B72C-40D3-B1B7-8F0AE5BA207AQ33521178-25101015-1656-4168-8AEE-C9A88E055657Q33685476-99AA5BB0-3A64-4DA2-B7C7-D9C7661139A8Q33996251-E657882E-AD26-4E04-901D-34249ABFEA1DQ34492862-417D9AC8-E2F4-4E62-A663-DC49D05DC32FQ34551634-2E02F412-AA9B-4850-9944-8210D738596BQ34570414-C805A549-BB73-4C4F-88EF-16578BCC7F71Q34708267-FF96D972-95E5-48FD-ABD7-0FB60F64E1F5Q34981291-54164078-7D27-419F-BE22-181FE1C098BEQ35100405-B73BA520-2C4A-4902-B483-83D52337100CQ36055050-40306BBC-68DB-4702-9719-4D4F211E04A7Q36079723-CC2FE0CE-48AB-4E16-B25C-85CD399674A1Q36365495-1E26D515-68F2-48D9-9D65-5B2B19857474Q36696900-1D85434A-D15F-4562-9B19-17961019E88AQ36954775-8EFA35A7-A37F-47C9-8E77-DB13675E6838Q37259818-620CCCCA-1EA8-41FC-A86B-57A7AAC106F2Q37402181-01FF9697-2148-46A3-A158-97C6EEB4B196Q37420927-66AD4255-89A7-4A23-A3EF-890837EFDF67Q37444732-519DD65B-3FD4-434B-BA24-FB062D3AEB11Q37612344-EE9B6070-7BF7-4E68-8954-18CF78D07E67Q37862989-70482251-09C4-4F46-9104-595B0E49A411Q38050769-6780DFB2-504C-4E73-A518-7972420CC4A0Q38149325-820E8A02-18A1-4A38-A9F1-055055BEFE34Q38584194-5E29F371-828F-4F08-A58E-628DCDC64ECDQ38725839-8775A577-76EE-4FA1-8D3F-F23DB19E2F89Q38797407-E26CDB96-BFEC-47B8-AA90-8F4DD1BC6902Q38922371-D20364F0-5806-4688-B776-D7BCAE694E1BQ39168306-7416B635-B01F-4ED0-B099-487F6BE68383Q39195751-A85C51B4-4757-4704-9471-8F4806ABD501Q40611452-69392DEF-799F-43DB-95FE-E2B3BBB185C3Q40938971-C4C15DF0-AF89-451F-9F97-848F41B12F53Q41767609-2231FBD2-C87C-4B2C-8564-0C60A7E96E36Q41953198-DD66354F-4506-4E77-9DD3-08FDE6C1F757Q41982613-CAB9B81B-69C9-4444-BE2C-7B188092F2D0Q42025945-057F18B7-1893-4475-A35F-26292E72D5C3Q42647710-AEA39747-9F0A-433F-9369-B62094507615
P2860
Management of glaucoma: focus on pharmacological therapy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Management of glaucoma: focus on pharmacological therapy.
@ast
Management of glaucoma: focus on pharmacological therapy.
@en
type
label
Management of glaucoma: focus on pharmacological therapy.
@ast
Management of glaucoma: focus on pharmacological therapy.
@en
prefLabel
Management of glaucoma: focus on pharmacological therapy.
@ast
Management of glaucoma: focus on pharmacological therapy.
@en
P1433
P1476
Management of glaucoma: focus on pharmacological therapy.
@en
P2093
Jess T Whitson
Robert E Marquis
P356
10.2165/00002512-200522010-00001
P407
P577
2005-01-01T00:00:00Z
P6179
1045684225